Patrick T. Horn

Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema

Marco Cicardi, Robyn J. Levy, Donald McNeil et al. · New England Journal of Medicine · 2010 · 299 citations · Full text

The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression

William R. Lumry, Anthony J. Castaldo, Margaret Vernon et al. · Allergy and Asthma Proceedings · 2010 · 281 citations

Quality Of Life, Family Medicine, Health Outcome +26

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial

Joseph S. Solomkin, David C. Evans, Algirdas Šlepavičius et al. · JAMA Surgery · 2016 · 250 citations

Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial

Richard J. Thompson, Henrik Arnell, Reha Artan et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 157 citations · Full text

EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema

Robyn J. Levy, William R. Lumry, Donald McNeil et al. · Annals of Allergy Asthma & Immunology · 2010 · 140 citations

Subcutaneous Ecallantide Treatment, Hereditary Angioedema, Angiology +3